首页> 外文OA文献 >Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: A unique and effective approach to coronary artery thrombolysis

【2h】

Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: A unique and effective approach to coronary artery thrombolysis

机译：逆行冠状静脉注射重组组织型纤溶酶原激活物：一种独特而有效的冠状动脉溶栓方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Miyazaki Akira; Tadokoro Hiroyuki; Drury J.Kevin; Rydén Lars; Haendchen Roberto V.; Corday Eliot;
展开▼
作者单位

展开▼
年度 1991
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator. [J] . Garber PJ, Gu S, Ducas J, Journal of critical care . 1995,第1期

机译：低主动脉压力的增加会增加静脉内施用重组组织纤溶酶原激活剂引起的冠状动脉血流量和冠状动脉溶栓作用。
2. An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator. [J] . Garber PJ, Gu S, Ducas J, Journal of critical care . 1995,第1期

机译：低主动脉压力的增加会增加静脉内施用重组组织纤溶酶原激活剂引起的冠状动脉血流量和冠状动脉溶栓作用。
3. Thrombolysis with Intracoronary Administration of YM866, a Novel Modified Tissue-Type Plasminogen Activator, in a Canine Model of Coronary Artery Thrombosis [J] . Chuichi Kawai, Hiroshi Gushima, Masao Katoh, Japanese Journal of Pharmacology . 1993,第3期

机译：冠状动脉内血栓形成犬模型中的新型修饰的组织型纤溶酶原激活物YM866的冠状动脉内溶栓治疗。
4. Plasminogen Activator Inhibitor I (PAI-I) -675 5G/4G Polymorphism in Patients with Coronary Artery Disease [C] . G. Apergis, M. Belia, A. Bratsas, International Congress on Thrombosis . 2004

机译：冠状动脉疾病患者的纤溶酶原激活剂抑制剂I（PAI-I）-675 5G / 4G多态性
5. The impact of electronic clinical reminders on medication trends and six-month survival after coronary artery bypass graft surgery in the Veterans Healthcare Administration. [D] . Strock, Cynthia Lynn. 2007

机译：在退伍军人医疗管理局中，电子临床提醒对药物趋势和冠状动脉搭桥手术后六个月生存的影响。
6. Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates. [O] . W Flameng, F Van de Werf, J Vanhaecke, 1985

机译：静脉输注非人类灵长类动物中的重组组织型纤溶酶原激活剂后冠状动脉溶栓和梗塞面积减少。
7. Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk [O] . Zmudka Krzysztof, Aubert Andre, Dubiel Jacek, 1994

机译：在狗体内血栓性冠状动脉闭塞后，早期静脉内给予美托洛尔通过使用重组组织型纤溶酶原激活剂进行溶栓治疗可增强心肌救助，从而改善了进入危险区域的侧支血流
8. Effect of Ultrasound on Tissue-Type Plasminogen Activator-Induced Thrombolysis [R] . Lauer, C. G., Burge, R., Tang, D. B., 1992

机译：超声对组织型纤溶酶原激活物诱导溶栓的影响

Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: A unique and effective approach to coronary artery thrombolysis

著录项

引文网络

相似文献

相关主题

期刊订阅